Clinical Trial Update: Senicapoc in Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on Senicapoc for Alzheimer's disease and mild cognitive impairment; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• Senicapoc (senicapoc)

Snippet

Sponsor: University of California, Davis | Conditions: Mild Cognitive Impairment, Alzheimer Disease | Phase 2 | Status: RECRUITING